Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B [Phase 3]

View source ↗

Summary

Results from a Phase 3 study of PF-06838435 gene therapy for Hemophilia B have been posted, evaluating efficacy and safety in adult males with moderately severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• PF-06838435

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-03-27